Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies

The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by accurate diagnosis early in life. However, it is not common to consider PIDs before the manifestation of severe clinical symptoms. Including PIDs in the nation-wide newborn screening programs will potentially improve survival and provide better disease management and preventive care in PID patients. This calls for the detection of disease biomarkers in blood and the use of dried blood spot samples, which is a part of routine newborn screening programs worldwide. Here, we developed a newborn screening method based on multiplex protein profiling for parallel diagnosis of 22 innate immunodeficiencies affecting the complement system and respiratory burst function in phagocytosis. The proposed method uses a small fraction of eluted blood from dried blood spots and is applicable for population-scale performance. The diagnosis method is validated through a retrospective screening of immunodeficient patient samples. This diagnostic approach can pave the way for an earlier, more comprehensive and accurate diagnosis of complement and phagocytic disorders, which ultimately lead to a healthy and active life for the PID patients.

Citing Articles

A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.

Shibata H, Nakajima D, Konno R, Hijikata A, Higashiguchi M, Nihira H J Clin Immunol. 2024; 45(1):33.

PMID: 39453496 PMC: 11511704. DOI: 10.1007/s10875-024-01821-7.

Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections.

Fredolini C, Dodig-Crnkovic T, Bendes A, Dahl L, Dale M, Albrecht V Commun Med (Lond). 2024; 4(1):55.

PMID: 38565620 PMC: 10987641. DOI: 10.1038/s43856-024-00480-4.

Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations.

King J, Grill K, Hammarstrom L Int J Neonatal Screen. 2023; 9(2).

PMID: 37092516 PMC: 10123688. DOI: 10.3390/ijns9020022.

Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm.

la Marca G, Carling R, Moat S, Yahyaoui R, Ranieri E, Bonham J Int J Neonatal Screen. 2023; 9(1).

PMID: 36975853 PMC: 10057559. DOI: 10.3390/ijns9010015.

Future Perspectives of Newborn Screening for Inborn Errors of Immunity.

Blom M, Bredius R, van der Burg M Int J Neonatal Screen. 2021; 7(4).

PMID: 34842618 PMC: 8628921. DOI: 10.3390/ijns7040074.

References

Skattum L, van Deuren M, van der Poll T, Truedsson L . Complement deficiency states and associated infections. Mol Immunol. 2011; 48(14):1643-55. DOI: 10.1016/j.molimm.2011.05.001. View

Tangye S, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A . Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40(1):24-64. PMC: 7082301. DOI: 10.1007/s10875-019-00737-x. View

Colobran R, Franco-Jarava C, Martin-Nalda A, Baena N, Gabau E, Padilla N . Novel Mutations Causing C5 Deficiency in Three North-African Families. J Clin Immunol. 2016; 36(4):388-96. DOI: 10.1007/s10875-016-0275-4. View

Schwenk J, Gry M, Rimini R, Uhlen M, Nilsson P . Antibody suspension bead arrays within serum proteomics. J Proteome Res. 2008; 7(8):3168-79. DOI: 10.1021/pr700890b. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Kwan A, Abraham R, Currier R, Brower A, Andruszewski K, Abbott J . Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014; 312(7):729-38. PMC: 4492158. DOI: 10.1001/jama.2014.9132. View

Hamsten C, Skattum L, Truedsson L, von Dobeln U, Uhlen M, Schwenk J . Heat differentiated complement factor profiling. J Proteomics. 2015; 126:155-62. DOI: 10.1016/j.jprot.2015.05.027. View

King J, Hammarstrom L . Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. J Clin Immunol. 2017; 38(1):56-66. PMC: 5742602. DOI: 10.1007/s10875-017-0455-x. View

Dezfouli M, Vickovic S, Iglesias M, Nilsson P, Schwenk J, Ahmadian A . Magnetic bead assisted labeling of antibodies at nanogram scale. Proteomics. 2013; 14(1):14-8. DOI: 10.1002/pmic.201300283. View

10.

Franco-Jarava C, Colobran R, Mestre-Torres J, Vargas V, Pujol-Borrell R, Hernandez-Gonzalez M . Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation. Immunol Lett. 2016; 174:19-22. DOI: 10.1016/j.imlet.2016.04.011. View

11.

Alba-Dominguez M, Lopez-Lera A, Garrido S, Nozal P, Gonzalez-Granado I, Melero J . Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion. Orphanet J Rare Dis. 2012; 7:42. PMC: 3458969. DOI: 10.1186/1750-1172-7-42. View

12.

Ignjatovic V, Pitt J, Monagle P, Craig J . The utility of dried blood spots for proteomic studies: looking forward to looking back. Proteomics Clin Appl. 2014; 8(11-12):896-900. DOI: 10.1002/prca.201400042. View

13.

Slade C, Bosco J, Unglik G, Bleasel K, Nagel M, Winship I . Deficiency in complement factor B. N Engl J Med. 2013; 369(17):1667-9. DOI: 10.1056/NEJMc1306326. View

14.

Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schaffer A . HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2006; 39(1):86-92. DOI: 10.1038/ng1940. View

15.

Grumach A, Kirschfink M . Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014; 61(2):110-7. DOI: 10.1016/j.molimm.2014.06.030. View

16.

Borte S, von Dobeln U, Fasth A, Wang N, Janzi M, Winiarski J . Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood. 2011; 119(11):2552-5. DOI: 10.1182/blood-2011-08-371021. View

17.

Biesma D, Hannema A, van Velzen-Blad H, Mulder L, van Zwieten R, Kluijt I . A family with complement factor D deficiency. J Clin Invest. 2001; 108(2):233-40. PMC: 203023. DOI: 10.1172/JCI12023. View

18.

Horiuchi T, Ferrer J, Serra P, Matamoros N, Lopez-Trascasa M, Hashimura C . A novel nonsense mutation at Glu-631 in a Spanish family with complement component 7 deficiency. J Hum Genet. 1999; 44(3):215-8. DOI: 10.1007/s100380050146. View

19.

Turley A, Gathmann B, Bangs C, Bradbury M, Seneviratne S, Gonzalez-Granado L . Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. J Clin Immunol. 2015; 35(2):199-205. DOI: 10.1007/s10875-015-0137-5. View

20.

Lim M, Elenitoba-Johnson K . The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004; 6(2):59-83. PMC: 1867474. DOI: 10.1016/S1525-1578(10)60493-X. View